CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2023

Dec 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICALS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2023-12-05

Reporting Person: Miller Steve (Chief Op. & Scientific Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-12-05	Common stock, par value $0.001 per share	S	40000	$14.24	Disposed	647457	Direct

Footnotes

F1: Shares were sold to fund the exercise price and tax withholding associated with the exercise of a stock option that will expire on January 3, 2024 and not as a result of any disagreement with the Company.

F2: Represents a weighted average price for the shares sold. Shares were sold in a range from $14.23 to $14.26 per share.